# Montelukast Sodium

NDC: 55111-725
Generic name: Montelukast Sodium
Labeler / Manufacturer: Dr.Reddy's Laboratories Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20120806

FDA application: ANDA201582

## Active ingredients

- MONTELUKAST SODIUM: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55111-725"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55111-725
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d4451a9-d73d-b9de-68ec-853bfeff6e4b